Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Clinical Trials & Guidelines: Why They Matter - News Directory 3

Clinical Trials & Guidelines: Why They Matter

June 6, 2025 Health
News Context
At a glance
  • Inspired by patients questioning if⁤ diabetes is reversible, ⁢the DiRECT trial⁣ in ‍the United ⁢kingdom integrated the Counterweight ⁤Program into primary care.
  • The DiRECT trial's weight management programs ⁣included meal replacements with liquid diets for up to 20 weeks, a gradual reintroduction of food, and consistent counseling.
  • The research confirms that diabetes remission ⁣is achievable ⁢through lifestyle changes.
Original source: ajmc.com

Discover how ⁣structured weight management programs are reshaping the landscape of diabetes treatment. The DiRECT⁤ trial unveils surprising findings: diabetes remission is within reach for some through strategic ‍interventions.This pivotal study, conducted in the United Kingdom, highlights that integrating programs like the Counterweight Programme into primary care can lead to notable improvements. Approximately ‍46% of newly diagnosed, non-insulin-dependent diabetes patients achieved remission.

Successful weight loss, specifically a 15-20% reduction, dramatically boosts the possibility of maintaining this positive outcome. ⁢While weight management programs⁣ offer hope, sustaining long-term weight ‍loss proves to be a considerable challenge, with remission rates diminishing over five years. Early intervention, alongside accessible and cost-effective programs, appears crucial. This research underscores the need for ongoing support and innovative⁤ strategies. For essential medical information, turn to News Directory 3.Eager to know how this evolving field will address ⁤the‍ enduring obstacle of long-term weight maintenance? Discover what’s next in the fight against diabetes.

Key Points

  • The DiRECT trial showed diabetes remission ⁣is possible through ⁣structured weight management.
  • Important weight loss (15-20%)⁣ improves the likelihood of maintaining remission.
  • Long-term ⁤weight maintenance remains a key challenge in diabetes⁢ management.

Weight Management Programs Offer Hope for Diabetes Remission

⁣ ‍ ‍ Updated June 06, 2025

Inspired by patients questioning if⁤ diabetes is reversible, ⁢the DiRECT trial⁣ in ‍the United ⁢kingdom integrated the Counterweight ⁤Program into primary care. The results indicated that structured weight management interventions ⁤can indeed lead to diabetes remission. After one⁤ year, about 46% of newly⁢ diagnosed diabetes patients, who were not on insulin, achieved hemoglobin A1c levels below 6.5%, technically achieving remission.

The DiRECT trial’s weight management programs ⁣included meal replacements with liquid diets for up to 20 weeks, a gradual reintroduction of food, and consistent counseling. Patients⁢ who achieved a 15-20% reduction in ‍their initial weight were more likely to sustain remission. However, maintaining this weight loss proved challenging,⁢ with remission rates⁣ dropping to approximately ⁢12-15% after five years, underscoring the difficulty of making lasting lifestyle changes.

The research confirms that diabetes remission ⁣is achievable ⁢through lifestyle changes. Tho, successful programs must⁤ be easily accessible, cost-effective, and designed to continuously engage patients. ⁣Early intervention for weight reduction is crucial for improving metabolic parameters and potentially achieving diabetes remission, though long-term weight⁢ maintenance remains‍ an ongoing hurdle.

What’s next

Further research is needed⁤ to develop lasting strategies for long-term weight maintenance, ⁢ensuring that diabetes remission achieved through intensive programs like DiRECT can be sustained ⁣over a patient’s lifetime.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related reading

  • From Discovery to Translation: The Evolution of iPSC Therapies
  • Metformin Shows No Cardiovascular Benefit in HFrEF: Met-HeFT Trial Results

Related

diabetes

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com